Aims and Objectives: This study was undertaken to highlight the resistance pattern of Nitrofurantoin among 5162 UTIs causing isolates at Microbiology Department of Dr. Lal Path Labs between April to June 2019. Materials and Methods: This retrospective study was performed in Department of Microbiology at Dr. Lal Path Labs, Delhi during period April to June 2019. Standard loopful midstream urine samples collected in a sterile container were inoculated on UTI Chromagar and incubated overnight at 37ºC and demonstrating significance colony count of ≥105 CFU/ml. Common Enterobacteriaceae group of isolates and Gram positive isolates identified by MALDI TOF-MS (Bruker, Daltonics) were included in this study. To determine Nitrofurantoin resistance by VITEK-AST (Biomerieux) system on 280/P628 antibiotic susceptibility testing cards respectively as per as CLSI M100-S-29. Proteus spp, Pseudomonas spp., Acinetobacter spp, of complicated UTI isolates were excluded from this study. Results: Of the 29485 urine samples tested during April to June 2019, 5162 (17.5%) were culture positive. Out of the 5162 positive isolates 2856 (55.3%) were isolated from female patients and 2306 (44.7%) from male patients. The most common bacterial isolates were members of Enterobacteriaceae 4728 (91.5%) and Gram positive were 434 (8.5%). The most predominant age group infected with uropathogens were elderly adults ≥ 50 years of age constituted 58.1% of the UTIs culture positive cases. Klebsiella pneumoniae demonstrated highest resistance of 92.3% whereas Staphylococcus aureus demonstrated the least resistance of 8.3%. Discussion and Conclusion: The alarming substantial resistance to Nitrofurantoin in decreasing order has been noticed in Enterobacteriaceae i.e., Klebsiella pneumonia (92.3%), Enterobacter spp.(58.2%), Citrobacter spp (42.6%) and Gram positive Enterococcus spp. (45.6%) which is across all age groups. Most susceptible to Nitrofurantoin were Escherichia coli (69.9%) in Gram negative and Staphylococcus aureus (91.7%) in Gram positive. This finding emphasis the need of robust restriction of Nitrofurantoin antibiotic policy and usage to uncomplicated UTIs caused by Escherichia coli and Staphylococcus aureus.
Objective: This study aimed at determining the prevalence and antifungal susceptibility pattern of Candida albicans and Nonalbicans Candida species from various clinical specimens tested in microbiology department of Dr Lal Path Labs, Delhi. Materials and Methods:This retrospective study conducted on 2240 samples, tested between January2019 to July 2019, performed at Microbiology department of Dr. Lal Path Labs. Yeast species were cultured by Conventional (culture) and identified by MALDI-TOF which followed by antifungal susceptibility testing was done using Vitek 2 YST YS07 card.Results: 737 Candida isolates of 16 diverse species were isolated from 2240 various clinical specimens. Candida albicans (54.9%) was predominant followed by C. tropicalis (14.7%), C. glabrata (11.7%), C. parapsilosis (4.3%), and C krusei (3.5%).Uncommon Candida species such as Candida auris, Rhodoturula mucilaginosa, Trichosporon asahii, Malassezia pachydermatitis, Kodameae ohmeri were also isolated. The most predominant age group infected with yeast isolates were elderly adults >=60 years of age which constituted 45.5% of the fungal culture positive cases. Alarming antifungal resistance noticed in Nonalbicans Candida species as compared to Candida albicans. In the present study, Candida albicans showed high resistance to newest generation Azole, Voriconazole (42.2%) whereas the burden of Echinocandin resistance is still alarming in Nonalbicans Candida infections. Conclusion:The fungal pathogens has changed over a period with new species emerging as well as old species increasing become more virulent and resistant to primary antifungal drugs. We should be concern about the national emergence of resistance among varying Candida species obtained in diverse clinical situations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.